These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31796333)

  • 1. Access to cancer medication in public hospitals in a middle-income country: The view of stakeholder.
    Moye-Holz D; Dreser A; van Dijk JP; Reijneveld SA; Hogerzeil HV
    Res Social Adm Pharm; 2020 Sep; 16(9):1255-1263. PubMed ID: 31796333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
    Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV
    BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
    Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
    Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country.
    Moye-Holz D; van Dijk JP; Reijneveld SA; Hogerzeil HV
    Global Health; 2017 Aug; 13(1):53. PubMed ID: 28764738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study.
    Xu S; Bian C; Wang H; Li N; Wu J; Li P; Lu H
    BMC Health Serv Res; 2015 Sep; 15():403. PubMed ID: 26394615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies.
    Kaplan WA; Ashigbie PG; Brooks MI; Wirtz VJ
    J Pharm Policy Pract; 2017; 10():17. PubMed ID: 28523128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the national health insurance scheme a pathway to sustained access to medicines in Nigeria?
    Uguru N; Ogu U; Uguru C; Ibe O
    BMC Health Serv Res; 2024 Mar; 24(1):403. PubMed ID: 38553711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
    Zhu Y; Wang Y; Sun X; Li X
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accessing medicines for non-communicable diseases: Patients and health care workers' experiences at public and private health facilities in Uganda.
    Tusubira AK; Akiteng AR; Nakirya BD; Nalwoga R; Ssinabulya I; Nalwadda CK; Schwartz JI
    PLoS One; 2020; 15(7):e0235696. PubMed ID: 32634164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous effects of health insurance on out-of-pocket expenditure on medicines in Mexico.
    Wirtz VJ; Santa-Ana-Tellez Y; Servan-Mori E; Avila-Burgos L
    Value Health; 2012; 15(5):593-603. PubMed ID: 22867767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to paediatric cancer care treatment in Mexico: responding to health system challenges and opportunities.
    Doubova SV; Knaul FM; Borja-Aburto VH; Garcia-Saíso S; Zapata-Tarres M; Gonzalez-Leon M; Sarabia-Gonzalez O; Arreola-Ornelas H; Pérez-Cuevas R
    Health Policy Plan; 2020 Apr; 35(3):291-301. PubMed ID: 31872242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health system determinants of access to essential medicines for children with cancer in Ghana.
    Boateng R; Renner L; Petricca K; Gupta S; Denburg A
    BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32967979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico.
    Moye-Holz D; van Dijk JP; Reijneveld SA; Hogerzeil HV
    Value Health Reg Issues; 2019 Dec; 20():129-135. PubMed ID: 31374426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of access to childhood cancer medicines: a comparative, mixed-methods analysis of four Caribbean countries.
    Boateng R; Petricca K; Tang B; Parikh S; SinQuee-Brown C; Alexis C; Browne-Farmer C; Reece-Mills M; Salmon SM; Bodkyn C; Gupta S; Maguire B; Denburg AE
    Lancet Glob Health; 2021 Sep; 9(9):e1314-e1324. PubMed ID: 34416215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new entity for the negotiation of public procurement prices for patented medicines in Mexico.
    Gómez-Dantés O; Wirtz VJ; Reich MR; Terrazas P; Ortiz M
    Bull World Health Organ; 2012 Oct; 90(10):788-92. PubMed ID: 23109747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers.
    Tang B; Bodkyn C; Gupta S; Denburg A
    JCO Glob Oncol; 2020 Feb; 6():67-79. PubMed ID: 32031441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dispensing prescriptions to persons affiliated with the Seguro Popular de Salud de México].
    Garrido-Latorre F; Hernández-Llamas H; Gómez-Dantés O
    Salud Publica Mex; 2008; 50 Suppl 4():S429-36. PubMed ID: 19082253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of performance metrics for the measurement of universal coverage for maternal care in Mexico.
    Serván-Mori E; Contreras-Loya D; Gomez-Dantés O; Nigenda G; Sosa-Rubí SG; Lozano R
    Health Policy Plan; 2017 Jun; 32(5):625-633. PubMed ID: 28453712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the dynamics of the Seguro Popular de Salud policy implementation in Mexico from a complex adaptive systems perspective.
    Nigenda G; González-Robledo LM; Juárez-Ramírez C; Adam T
    Implement Sci; 2016 May; 11():68. PubMed ID: 27177618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.